Atara Biotherapeutics Enters Agreement For Issuance And Sale Of Pre-Funded Warrants To Purchase 27,272,727 Shares Of Common Stock At $0.55 Per Pre-Funded Warrant Share In $15M Registered Direct Offering
Author: Benzinga Newsdesk | January 08, 2024 10:19am